Evidence map›Paper›PMID 31536177›Full record

ArticleJournal of the International AIDS Society2019

Liver cirrhosis in HIV/HCV-coinfected individuals is related to NK cell dysfunction and exhaustion, but not to an impaired NK cell modulation by CD4

María L Polo, Yanina A Ghiglione, Jimena P Salido, Alejandra Urioste, Gabriela Poblete, Alicia E Sisto, Ana Martinez, María J Rolón, Diego S Ojeda, Pedro E Cahn and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. The antifibrotic role of natural killer cells in liver fibrosis.Experimental biology and medicine (Maywood, N.J.) · 2022
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

María L PoloCONICET-Universidad de Buenos Aires, Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), Buenos Aires, Argentina.
Yanina A GhiglioneCONICET-Universidad de Buenos Aires, Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), Buenos Aires, Argentina.
Jimena P SalidoCONICET-Universidad de Buenos Aires, Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), Buenos Aires, Argentina.
Alejandra UriosteCONICET-Universidad de Buenos Aires, Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), Buenos Aires, Argentina.
Gabriela PobleteInfectious Diseases Unit, Hospital General de Agudos "Dr. JA Fernández", Buenos Aires, Argentina.
Alicia E SistoInfectious Diseases Unit, Hospital General de Agudos "Dr. JA Fernández", Buenos Aires, Argentina.
Ana MartinezGastroenterology Unit, Hospital General de Agudos "Dr. JA Fernández", Buenos Aires, Argentina.
María J RolónInfectious Diseases Unit, Hospital General de Agudos "Dr. JA Fernández", Buenos Aires, Argentina.
Diego S OjedaCONICET-Universidad de Buenos Aires, Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), Buenos Aires, Argentina.
Pedro E CahnFundación Huésped, Buenos Aires, Argentina.
Gabriela J TurkCONICET-Universidad de Buenos Aires, Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), Buenos Aires, Argentina.
Natalia L LauferCONICET-Universidad de Buenos Aires, Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), Buenos Aires, Argentina.ORCID 0000-0002-5690-9454
Consejo Nacional de Investigaciones Científicas y Técnicas · ARHospital Fernández · ARFundación Huésped · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHIV worsens HCV-related liver disease by accelerating fibrosis progression; however, progression rates are extremely variable among HIV/HCV-coinfected individuals. NK cells are associated with modulation of liver fibrosis and are profoundly altered during HCV and HIV infections. CD4

methodsThirty-four HIV/HCV-coinfected individuals with minimal (n = 16) and advanced (n = 18) fibrosis (METAVIR F0/F1 and F4 scores respectively) and 20 healthy volunteers were enrolled. PBMC were obtained from peripheral blood samples and NK and CD4

resultsWhen comparing to NK cells from individuals with minimal fibrosis, degranulation and cytokine secretion by NK cells from subjects with F4 scores was significantly impaired, while PD-1 expression was augmented. On the one hand, neither the expression of activation markers nor IL-2 secretion was distinctly induced in CD4

conclusionsLow levels of NK and CD4

Indexed as

AdultAgedCD4-Positive T-LymphocytesCoinfectionFemaleHepacivirusHepatitis CHIV-1HIV InfectionsHumansKiller Cells, NaturalLeukocytes, MononuclearLiver CirrhosisLymphocyte ActivationMaleMiddle AgedCD4-positive T-lymphocyteshepatitis C virusHIVImmunologyliver fibrosisNK cells

Identifiers

PMID31536177
PMCPMC6752153
OpenAlexW2973834767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.